Sisram Medical Dirección
Dirección controles de criterios 2/4
El CEO de Sisram Medical's es Lior Dayan , nombrado en Jun 2017, tiene una permanencia de 7.08 años. compensación anual total es $1.53M, compuesta por 56.6% salario y 43.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.2% de las acciones de la empresa, por valor de HK$3.38M. La antigüedad media del equipo directivo y de la junta directiva es de 1.5 años y 6.9 años, respectivamente.
Información clave
Lior Dayan
Chief Executive Officer (CEO)
US$1.5m
Compensación total
| Porcentaje del salario del CEO | 56.6% |
| Permanencia del CEO | 7.1yrs |
| Participación del CEO | 0.2% |
| Permanencia media de la dirección | 1.5yrs |
| Promedio de permanencia en la Junta Directiva | 6.9yrs |
Actualizaciones recientes de la dirección
Recent updates
Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)
Jun 17
Returns On Capital At Sisram Medical (HKG:1696) Have Stalled
Apr 21Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?
Mar 28Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)
Mar 05Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)
Jan 23Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?
Dec 29Is Sisram Medical (HKG:1696) Using Too Much Debt?
Nov 09Returns On Capital At Sisram Medical (HKG:1696) Have Stalled
Oct 19At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?
Sep 18Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year
Aug 14Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?
Jun 16Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue
May 30Is Sisram Medical (HKG:1696) Using Too Much Debt?
Apr 19Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?
Mar 01Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital
Jan 12Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet
Dec 21Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?
Dec 01Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital
Oct 14Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching
Sep 28These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely
Aug 25Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?
Aug 01These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely
May 19Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?
May 03If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late
Apr 11Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital
Mar 17Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?
Nov 22Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)
Aug 22Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital
Jul 27Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair
Jun 24Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital
Apr 16Sisram Medical (HKG:1696) Has A Pretty Healthy Balance Sheet
Mar 26Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$863k | US$31m |
| Sep 30 2023 | n/a | n/a | US$35m |
| Jun 30 2023 | n/a | n/a | US$38m |
| Mar 31 2023 | n/a | n/a | US$39m |
| Dec 31 2022 | US$3m | US$1m | US$40m |
| Sep 30 2022 | n/a | n/a | US$38m |
| Jun 30 2022 | n/a | n/a | US$35m |
| Mar 31 2022 | n/a | n/a | US$33m |
| Dec 31 2021 | US$2m | US$767k | US$31m |
| Sep 30 2021 | n/a | n/a | US$28m |
| Jun 30 2021 | n/a | n/a | US$24m |
| Mar 31 2021 | n/a | n/a | US$19m |
| Dec 31 2020 | US$769k | US$596k | US$13m |
| Sep 30 2020 | n/a | n/a | US$13m |
| Jun 30 2020 | n/a | n/a | US$13m |
| Mar 31 2020 | n/a | n/a | US$17m |
| Dec 31 2019 | US$759k | US$606k | US$21m |
| Sep 30 2019 | n/a | n/a | US$22m |
| Jun 30 2019 | n/a | n/a | US$24m |
| Mar 31 2019 | n/a | n/a | US$23m |
| Dec 31 2018 | US$884k | US$560k | US$22m |
| Sep 30 2018 | n/a | n/a | US$18m |
| Jun 30 2018 | n/a | n/a | US$14m |
| Mar 31 2018 | n/a | n/a | US$12m |
| Dec 31 2017 | US$829k | US$361k | US$11m |
Compensación vs. Mercado: La compensación total de Lior($USD2.66M) está por encima de la media de empresas de tamaño similar en el mercado Hong Kong ($USD339.94K).
Compensación vs. Ingresos: La compensación de Lior ha sido consistente con los resultados de la empresa en el último año.
CEO
Lior Dayan (54 yo)
7.1yrs
Permanencia
US$1,526,000
Compensación
Mr. Lior Moshe Dayan has been Chief Executive Officer and Executive Director at Sisram Medical Ltd since June 6, 2017 and its President since 2023 and is responsible for its overall and day-to-day manageme...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 8.3yrs | US$27.00k | 0.053% $ 890.0k | |
| President | 7.1yrs | US$1.53m | 0.20% $ 3.3m | |
| VP of Finance | 1.5yrs | sin datos | sin datos | |
| Chief Operating Officer | 6.3yrs | sin datos | sin datos | |
| Chief Information Officer | less than a year | sin datos | sin datos | |
| Chief Marketing Officer | 1.5yrs | sin datos | sin datos | |
| Chief People Officer | 1.5yrs | sin datos | sin datos | |
| President of ROW | 1.5yrs | sin datos | sin datos | |
| EVP of R&D | 1.5yrs | sin datos | sin datos | |
| President NA | 1.5yrs | sin datos | sin datos | |
| Company Secretary | 2.5yrs | sin datos | sin datos |
1.5yrs
Permanencia media
54yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de 1696 no se considera experimentado ( 1.3 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 8.3yrs | US$27.00k | 0.053% $ 890.0k | |
| President | 7.1yrs | US$1.53m | 0.20% $ 3.3m | |
| Independent Non-Executive Director | 6.9yrs | US$32.00k | sin datos | |
| Non-Executive Director | 7.8yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 6.9yrs | US$32.00k | sin datos | |
| Independent Non-Executive Director | 6.9yrs | US$32.00k | sin datos | |
| Independent Non-Executive Director | 6.9yrs | US$32.00k | sin datos | |
| Non-Executive Director | 3.9yrs | sin datos | sin datos |
6.9yrs
Permanencia media
51.5yo
Promedio de edad
Junta con experiencia: La junta directiva de 1696 se considera experimentada (6.7 años de antigüedad promedio).